NEW YORK (GenomeWeb) – Genome Compiler today announced a collaboration under which it will integrate DNA2.0's gene synthesis services into its computer-aided synthetic biology design platform.
"Direct connection to DNA2.0 services will simplify the design to order user experience, giving a more streamlined approach to the programming of living things," Omri Drory, CEO of Genome Compiler, said in a statement.
Genome Compiler, with offices in Los Altos, Calif. and Tel-Aviv, Israel, is a software developer creating computer-aided design and collaboration platforms for the synthetic biology industry.
Menlo Park, Calif.-based bioengineering firm DNA2.0 offers an integrated pipeline for designing, optimizing, and synthesizing genes and proteins.
In March, DNA2.0 licensed the technology underlying its Gene Designer software to Genome Compiler, ending a patent dispute between the two firms.
Financial and other terms of the deal were not disclosed.